Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatments for Apomorphine-induced Skin Reactions
NCT02230930Phase 2Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2015
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Alkindi Sprinkle in drug-induced skin eruption, sponsored by University Medical Center Groningen. Started Jun 2015; status: terminated.
02
Drugs
Alkindi Sprinkle
03
Conditions
drug-induced skin eruption
Beyond the preview
Go deeper on NCT02230930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230930.